MEDIROM Healthcare Technologies Research and Development Expenses 2021-2024 | MRM
MEDIROM Healthcare Technologies research and development expenses from 2021 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| MEDIROM Healthcare Technologies Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| MEDIROM Healthcare Technologies Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.039B | $0.055B |
| MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.766B | 19.48 |
| Encompass Health (EHC) | United States | $12.251B | 25.97 |
| DaVita (DVA) | United States | $10.652B | 14.98 |
| Chemed (CHE) | United States | $8.132B | 25.56 |
| Elanco Animal Health (ELAN) | United States | $7.102B | 15.21 |
| Option Care Health (OPCH) | United States | $5.240B | 23.36 |
| RadNet (RDNT) | United States | $4.356B | 276.43 |
| Amedisys (AMED) | United States | $3.217B | 21.64 |
| Addus HomeCare (ADUS) | United States | $2.128B | 23.36 |
| LifeStance Health (LFST) | United States | $1.975B | 0.00 |
| Astrana Health (ASTH) | United States | $1.386B | 34.33 |
| U.S Physical Therapy (USPH) | United States | $1.195B | 30.86 |
| Pennant (PNTG) | United States | $1.003B | 36.82 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.940B | 53.56 |
| Atai Life Sciences (ATAI) | Germany | $0.451B | 0.00 |
| Daxor (DXR) | United States | $0.047B | 0.00 |
| Ontrak (OTRK) | United States | $0.004B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |